Shohei Sakata

Statistics

Publications

Citations

140

H-Index

Active since

2009

Affiliations

Japan Tobacco (Japan)(Current)

Japan Tobacco (United States)

Shohei Sakata is an author at Japan Tobacco (Japan) specializing in pharmacology, insulin signaling in metabolism, and protein tyrosine phosphatase inhibitors.

Publications per year

2009–2018

Publications

Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT‐551

Sumiaki Fukuda, Takeshi Ohta, Shohei Sakata et al. · Diabetes Obesity and Metabolism · 2009 · 65 citations

Medicine, Endocrinology, Pharmacology +17

Pharmacological Effects of JTT-551, a Novel Protein Tyrosine Phosphatase 1B Inhibitor, in Diet-Induced Obesity Mice

Makoto Ito, Sumiaki Fukuda, Shohei Sakata et al. · Journal of Diabetes Research · 2014 · 32 citations · Full text

Life Sciences, Endocrinology, Pharmacology +16

Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity

Minoru Ubukata, Ikuo MITANI, Yuichi Nakagawa et al. · European Journal of Medicinal Chemistry · 2018 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis

Chihiro Okuma, Takeshi Ohta, Hironobu Tadaki et al. · Journal of Pharmacological Sciences · 2015 · 13 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

1–4 of 4